News Center
With the tenet of "Healthy China, Dedicated commitment", Linuo Pharmaceuticals increases cooperation and association with external scientific research institutes while innovating and developing independently.
01
2025
-
12
Let’s jointly draw up a blueprint for development! Linuo Pharmaceutical makes its debut at the 91st China Pharmaceutical Fair!
Classification：
行业新闻
Corporate News
The autumn hues of Jinling are rich and vibrant, and guests have been arriving from afar. On November 19, the 91st National Pharmaceutical Fair kicked off as scheduled in Nanjing. As a central platform for showcasing innovative achievements in the pharmaceutical sector and a key link for coordinating collaboration across the upstream and downstream segments of the industry chain, the Pharmaceutical Fair brings together a diverse array of participants—including renowned domestic and international pharmaceutical companies, seasoned distributors, medical institutions, and investment firms. It has witnessed groundbreaking technological advances and continuous product upgrades within the industry, playing an indispensable role in promoting high-quality development of the pharmaceutical sector, accelerating the distribution of high-quality medical resources to grassroots levels, and safeguarding people’s health.
New Product Launch: Intravenous Isavuconazole Sulfate
As this highly anticipated industry event kicks off, Linuo Pharmaceutical is making a strong appearance with its impressive achievements in intelligent manufacturing and an extensive product portfolio covering all categories. On the eve of the exhibition’s opening, the company grandly hosted a customer appreciation gala themed “Grateful for You—Building Dreams Together for Mutual Success.” Dozens of partners from across the country gathered together at the event, including representatives from publicly listed companies such as Guokong Holdings, Shangyao Holdings, China Resources Pharmaceutical, Huayuan Pharmaceutical, and Chongqing Boteng, as well as emerging leaders in the pharmaceutical sector. Together, these partners witnessed Linuo Pharmaceutical’s growth and breakthroughs.
At the gala dinner, Chairman Li Hongfu shared the company’s “Four Foundational Years” strategy—marking the inaugural year of internet thinking, the inaugural year of AI’s full-scenario applications, the inaugural year of data management, and the inaugural year of investment and financing—as well as the achievements made in the integration of intelligent manufacturing, product innovation, and capital. He also extended sincere gratitude to the partners who have long supported the company’s development.
The highlight of the gala dinner—the launch of a new injectable formulation of isavuconazole sulfate—lit up the entire audience with enthusiasm. The introduction of this product marks an important strategic move by Linuo Pharmaceutical in the field of fungal infection treatment, injecting strong momentum into its competitive edge in the anti-infection arena.
The gala dinner also featured several rounds of award ceremonies honoring outstanding strategic partners and agents, highlighting the company’s collaborative philosophy of “deep integration and mutual, long-term success” with its partners.
Echoing the lively atmosphere of the gala dinner, the booth that Linuo Pharmaceutical has specially designed for this Pharmaceutical Fair is now fully prepared and ready to go. Located at Booth B20 in Hall 8, the booth features a simple yet elegant design that comprehensively showcases the company’s strength in “multiple dosage forms and a full range of product categories.”
As soon as the new product, Esaxol sulfate for injection, was unveiled, it immediately drew the attention of numerous attendees. Li Hongfu, Chairman of the company, and Huang Fangsheng, President, led the marketing team in providing round-the-clock support, engaging in discussions and exchanges with both new and existing partners from across the country, thereby further deepening the intensity and breadth of our collaborations.
Accumulating multi-dimensional strengths to empower the path of high-quality development.
Being able to make a strong statement at industry events is underpinned by Linuo Pharmaceutical’s comprehensive and well-rounded strength and accumulation. 。
In the field of intelligent manufacturing, the company has in recent years been comprehensively promoting digital and intelligent transformation and upgrading, and has built first-class domestic and internationally benchmarked intelligent manufacturing bases, such as the Shanghe API base and the Jinan injectables base. The Shanghe base serves as a “stable cornerstone” for raw material supply. The Jinan base is a computing power center that connects various regions. This interconnected and mutually supportive smart manufacturing layout— Created a competitive advantage in energy conservation and cost reduction.
In terms of product matrix development, Linuo Pharmaceutical has achieved a transformative upgrade—from “single oral solid dosage forms” to “comprehensive coverage across multiple dosage forms”: Currently, the company has established a full-range product portfolio encompassing injections, oral solutions, drops, topical applications, pastes, sprays, and more, covering multiple therapeutic areas including chronic disease management, anti-inflammatory, and antibacterial treatments. Even more crucially, leveraging the synergistic advantages of “integrated raw material and formulation production” and “integrated excipient and formulation production,” the company has developed unique competitive strengths in cost control, quality assurance, and capacity allocation—self-sufficiency in raw materials reduces external dependency risks, while coordinated use of excipients enhances product stability, enabling Linuo Pharmaceutical to maintain flexibility and resilience in the fiercely competitive market.
In terms of capital support and product deployment, Lino Pharmaceutical is not merely “following market demand”; rather, it uses capital as a “precise navigator” to strategically plan its short-, medium-, and long-term product development strategies. Leveraging the capital advantages of a publicly listed company and the production capacity benefits of intelligent manufacturing, Lino Pharmaceutical is steadily moving toward its goal of becoming a leading enterprise that boasts “sustainable profitability, a clear growth trajectory, and deep industry barriers.”
In terms of brand building, the company is guided by the mission of "caring for life and health, and safeguarding a better life." It has integrated "long-termism, product-centricity, and altruism" into its very core, and further embeds these brand values into every industry-related initiative: consistently appearing at prominent industry events such as the China Pharmaceutical Fair, the China International Pharmaceutical Industry Fair, and the Wuzhen Health Conference—without... Continuously enhance brand influence and industry reputation.
Amid the wave of transformation in the pharmaceutical industry, Linuo Pharmaceutical—grounded in intelligent manufacturing, armed with a diversified product portfolio, empowered by strategic capital partnerships, and driven by a strong brand culture—is steadily advancing toward an even broader market stage.
A true friend is found within the seas; though miles apart, we’re as close as neighbors. Together, we lay the foundation for a shared enterprise and strive toward a common future of mutual success. The curtain has already risen on the Pharmaceutical Fair, and Linuo Pharmaceutical kicks off the event with a warm and heartfelt thank-you dinner. The launch of our new product—Esaconazole Sulfate Injection—serves as our powerful voice, while our comprehensive booth showcases our strength and capabilities. Every step we take remains firmly rooted in our original aspiration: to thrive alongside our partners and share prosperity with the entire industry. Linuo Pharmaceutical is eager to join hands with all our partners, standing side by side to pursue our shared dreams and co-create a golden age for China’s pharmaceutical and healthcare sector.
Related news
ADD：#30766 Jingshidong Road, Linuo High-tech Park, Jinan, Shandong Province, P. R. China
